2026
-
Clinical Year in Review Series Begins with Insights on Asthma, Pulmonary Vascular Disease, Vaccines, and Sleep Medicine
on
Read more: Clinical Year in Review Series Begins with Insights on Asthma, Pulmonary Vascular Disease, Vaccines, and Sleep MedicineThe first session of the ATS 2026 International Conference Clinical Year in Review series, held on Sunday, May 17, in Orlando, contextualized evolving evidence, practice implications, and unmet needs in asthma, pulmonary vascular disease, vaccines, and sleep medicine.
-
Second Clinical Year in Review Session Tackles High-Yield Research in Acute Respiratory Distress Syndrome, Critical Care, Sepsis, and Post-ICU Care
on
Read more: Second Clinical Year in Review Session Tackles High-Yield Research in Acute Respiratory Distress Syndrome, Critical Care, Sepsis, and Post-ICU CareThe Clinical Year in Review series continued Monday, May 18, at ATS 2026 Orlando with a review of key lessons from both positive and negative trial findings in acute respiratory distress syndrome and acute hypoxemic respiratory failure, critical care, sepsis, and post-ICU care.
-
Third Clinical Year in Review Session Spotlights Key Advances in ILD, Lung Transplant, and More
on
Read more: Third Clinical Year in Review Session Spotlights Key Advances in ILD, Lung Transplant, and MoreThe third ATS 2026 International Conference Clinical Year in Review session on Tuesday, May 19, featured experts discussing updates to guidelines and impactful studies in cystic fibrosis and non-CF bronchiectasis, interstitial lung disease, lung transplant, and environmental lung diseases.
-
Final Clinical Year in Review Session Shares State-of-The-Art Science in COPD, Interventional Pulmonary Medicine, Medical Education, and Lung Cancer
on
Read more: Final Clinical Year in Review Session Shares State-of-The-Art Science in COPD, Interventional Pulmonary Medicine, Medical Education, and Lung CancerThe ATS 2026 Orlando Clinical Year in Review series concluded on Wednesday, May 20, with an expert-curated summary of recent advances across the clinical care continuum in COPD, interventional pulmonary medicine, medical education, and lung cancer.
-
Tuesday Keynote Explains How to Leverage Artificial Intelligence to Augment Professional Education
on
Read more: Tuesday Keynote Explains How to Leverage Artificial Intelligence to Augment Professional EducationArtificial intelligence (AI) is rapidly transforming health care delivery and medical education — its integration demands both enthusiasm and caution. In Tuesday’s final Keynote Series presentation of the ATS 2026 International Conference, Laurah Turner, PhD, associate dean for AI and Educational Informatics at the University of Cincinnati College of Medicine, provided a framework for understanding…
-
Plenary Speaker Chronicles Her Remarkable Journey and the Redemptive Power of Hope
on
Read more: Plenary Speaker Chronicles Her Remarkable Journey and the Redemptive Power of HopeRana L. Awdish, MD, MS, author of the bestselling medical memoir, In Shock: My Journey from Death to Recovery and the Redemptive Power of Hope, shared her remarkable story during Tuesday’s Plenary Session at the ATS International Conference. After a life-threatening rupture in her liver, Dr. Awdish underwent an arduous, transformative journey to recovery that…
-
President’s Symposium Traces History, Plots Future of PAH Therapeutic Pathways
on
Read more: President’s Symposium Traces History, Plots Future of PAH Therapeutic PathwaysOver the past 40 years, pulmonary arterial hypertension (PAH) has been transformed into a treatable chronic condition thanks to advances in vascular biology, such as the identification of prostacyclin deficiency, endothelin overexpression, impaired nitric oxide signaling, and dysregulated activin signaling. The President’s Symposium on Monday offered expert-driven insights into the history behind PAH therapeutic pathways…
-
Recognition Awards for Scientific Accomplishments Honors Four Trailblazing Investigators
on
Read more: Recognition Awards for Scientific Accomplishments Honors Four Trailblazing InvestigatorsThe recipients of the Recognition Awards for Scientific Accomplishments were honored on Monday afternoon at ATS 2026 Orlando. The four honorees shared inspiring accounts of their careers and the seminal contributions that advanced their field’s fundamental understanding of lung pathophysiology and pulmonary clinical care.
-
Proposal for Restoring Communication and Agency to ICU Patients Wins 2026 BEAR Cage Competition
on
Read more: Proposal for Restoring Communication and Agency to ICU Patients Wins 2026 BEAR Cage CompetitionEmily Mitchell, MD, was named the winner of the 12th Annual BEAR Cage Competition on Monday at the ATS 2026 International Conference. Her pitch, “Breaking the Silence: Eye-Tracking for Restoring Patient Agency and Communication in the ICU,” featured an innovative concept to restore communication for ICU-intubated patients.
-
Early Career Programs Help Next Generation Navigate Respiratory Science, Skills, and Scenarios
on
Read more: Early Career Programs Help Next Generation Navigate Respiratory Science, Skills, and ScenariosMore than 500 participants prepared for the next steps in their respiratory medicine journeys during the pre-conference Early Career Programs in Orlando. The programs featured lectures and discussions on professionally relevant science, hands-on skills training, and networking opportunities with ATS community members.